Articles related to GLOBAL HEALTH

The WHO notes significant diagnostic challenges in differentiating Lassa fever from similar viral infections due to varied and non-specific presentation.

Twice-yearly azithromycin distribution to children aged 1-59 months reduced all-cause mortality by 14% compared to placebo, even in communities with lower baseline mortality rates and ongoing malaria prevention efforts.

The emergence of a new, potentially more virulent mpox strain (clade 1b) in Africa has prompted renewed international concern and action.